ARCHIVES

FDA Deputy Commissioner Gottlieb To Return To AEI.

This article is from The Cancer Letter archive.

Vol. 32 No. 45 | December 15, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says

August 10, 1979

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008